Perspectives of HER2-targeting in Gastric and Esophageal Cancer

Expert Opinion on Investigational Drugs - United Kingdom
doi 10.1080/13543784.2017.1315406
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Loss of HER2 Positivity After Anti-Her2 Chemotherapy in HER2-positive Gastric Cancer Patients: Results of the GASTric Cancer HER2 Reassessment Study 3 (GASTHER3)

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2018English

Prognostic Implications of HER2 Heterogeneity in Gastric Cancer

Oncotarget
Oncology
2018English

HER2 Testing in Gastric Cancer: A Practical Approach

Modern Pathology
Forensic MedicinePathology
2012English

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer

Scientific Reports
Multidisciplinary
2017English

Ramucirumab: Successfully Targeting Angiogenesis in Gastric Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Droplet Digital PCR Measurement of HER2 in Patients With Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

A Case of Double Cancer of Multiple Esophageal Cancer and Multiple Gastric Cancer

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2007English

Targeting the Function of the HER2 Oncogene in Human Cancer Therapeutics

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy